Fund Holdings — Vestal Point Capital, LP

Total Portfolio Value:
$3.87B
Total Bought:
$1.14B
Total Sold:
$1.32B
Net Transaction:
-$176.18M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX Société AnonymeADS(ABVX)2,349,4433,960,000+1,610,557$313.09M$392.12M10.13%+$79.03M
Neurocrine Biosciences, Inc.(NBIX)1,880,0002,500,000+620,000$316.85M$354.60M9.16%+$37.75M
BioMarin Pharmaceutical Inc.(BMRN)6,025,0005,525,000-500,000$344.75M$331.50M8.56%-$13.25M
Arrowhead Pharmaceuticals, Inc.(ARWR)1,575,0004,815,000+3,240,000$128.38M$315.14M8.14%+$186.76M
Insmed Incorporated(INSM)250,0002,725,000+2,475,000$26.66M$311.03M8.04%+$284.38M
United Therapeutics Corporation(UTHR)435,000475,000+40,000$235.70M$257.40M6.65%+$21.70M
Ascendis Pharma A/S(ASND)375,000740,000+365,000$100.02M$168.59M4.36%+$68.57M
Nurix Therapeutics, Inc.(NRIX)8,050,0007,025,000-1,025,000$195.29M$166.56M4.30%-$28.73M
Tarsus Pharmaceuticals, Inc.(TARS)1,050,0002,033,625+983,625$66.09M$159.86M4.13%+$93.78M
Enliven Therapeutics Inc4,000,0003,225,000-775,000$203.00M$147.83M3.82%-$55.17M
Disc Medicine, Inc.(IRON)1,550,0001,635,000+85,000$113.37M$107.03M2.77%-$6.34M
Bicara Therapeutics Inc5,250,0005,525,000+275,000$155.87M$102.82M2.66%-$53.05M
Dyne Therapeutics, Inc.(DYN)3,375,0006,200,000+2,825,000$74.96M$99.88M2.58%+$24.92M
Immatics N.V.SHS(IMTX)6,175,00011,200,000+5,025,000$62.55M$98.34M2.54%+$35.78M
Taysha Gene Therapies, Inc.(TSHA)19,415,00018,045,000-1,370,000$132.22M$87.88M2.27%-$44.34M
Monte Rosa Therapeutics Inc4,600,0007,130,000+2,530,000$111.32M$85.06M2.20%-$26.26M
Globus Medical, Inc.CL A(GMED)850,000915,000+65,000$67.16M$68.53M1.77%+$1.38M
Crescent Biopharma Inc1,630,0003,000,000+1,370,000$29.34M$43.77M1.13%+$14.43M
Zimmer Biomet Holdings, Inc.(ZBH)1,400,000475,000-925,000$120.53M$42.19M1.09%-$78.33M
Travere Therapeutics, Inc.(TVTX)0600,000+600,000$0$35.33M0.91%+$35.33M
Arcus Biosciences, Inc.(RCUS)01,300,000+1,300,000$0$33.58M0.87%+$33.58M
Xenon Pharmaceuticals Inc.(XENE)700,000850,000+150,000$42.25M$31.61M0.82%-$10.64M
Nektar Therapeutics(NKTR)1,000,000510,000-490,000$69.81M$30.88M0.80%-$38.93M
Bright Minds Biosciences Inc545,000545,0000$38.26M$27.15M0.70%-$11.11M
BridgeBio Pharma, Inc.(BBIO)0400,000+400,000$0$26.32M0.68%+$26.32M
Immunocore Holdings plcADS(IMCR)1,800,000850,000-950,000$57.15M$25.75M0.67%-$31.40M
Insulet Corporation(PODD)670,000175,000-495,000$102.01M$22.83M0.59%-$79.18M
Trevi Therapeutics, Inc.(TRVI)3,100,0001,495,000-1,605,000$57.81M$21.41M0.55%-$36.41M
SanofiADR(SNY)2,000,000500,000-1,500,000$85.32M$20.61M0.53%-$64.70M
Savara Inc.(SVRA)2,720,0003,300,000+580,000$16.76M$17.03M0.44%+$272.8K
SpyGlass Pharma, Inc.(SGP)670,000640,000-30,000$14.91M$16.64M0.43%+$1.73M
Zymeworks Inc.(ZYME)0600,000+600,000$0$15.89M0.41%+$15.89M
Cogent Biosciences, Inc.(COGT)0475,000+475,000$0$15.21M0.39%+$15.21M
Solid Biosciences Inc2,160,0002,085,000-75,000$21.58M$15.07M0.39%-$6.50M
Lexeo Therapeutics Inc4,320,0004,320,0000$20.11M$14.60M0.38%-$5.51M
Avalo Therapeutics Inc775,000800,000+25,000$14.32M$12.26M0.32%-$2.06M
Zenas BioPharma, Inc.(ZBIO)365,000395,000+30,000$9.26M$10.65M0.28%+$1.39M
Evommune Inc1,000,0001,250,000+250,000$13.29M$10.32M0.27%-$2.96M
Viking Therapeutics, Inc.(VKTX)680,000290,000-390,000$26.53M$9.45M0.24%-$17.07M
Stoke Therapeutics, Inc.(STOK)0345,000+345,000$0$8.97M0.23%+$8.97M
Korsana Biosciences Inc0263,105+263,105$0$8.42M0.22%+$8.42M
Damora Therapeutics Inc0395,000+395,000$0$8.41M0.22%+$8.41M
Tectonic Therapeutic Inc425,000360,000-65,000$14.61M$8.38M0.22%-$6.22M
Zura Bio LtdCL A1,173,9561,860,000+686,044$6.93M$7.74M0.20%+$811.3K
Glaukos Corporation(GKOS)045,000+45,000$0$7.39M0.19%+$7.39M
Kailera Therapeutics Inc575,000625,000+50,000$12.67M$7.14M0.18%-$5.53M
Anteris Technologies Global Co1,010,000850,000-160,000$9.95M$6.60M0.17%-$3.34M
MoonLake ImmunotherapeuticsCL A(MLTX)0525,000+525,000$0$6.14M0.16%+$6.14M
Rezolute Inc382,9991,455,000+1,072,001$1.99M$6.02M0.16%+$4.03M
First Tracks Biotherapeutics I1,013,000169,738-843,262$20.38M$6.02M0.16%-$14.37M
Voyager Therapeutics Inc2,625,0002,165,000-460,000$9.19M$5.80M0.15%-$3.39M
Maze Therapeutics, Inc.(MAZE)0175,000+175,000$0$4.76M0.12%+$4.76M
Olema Pharmaceuticals Inc418,551420,000+1,449$5.24M$3.63M0.09%-$1.61M
Palisade Bio Inc2,500,0002,500,0000$5.22M$3.38M0.09%-$1.85M
enGene Therapeutics Inc1,667,4301,665,000-2,430$2.88M$3.33M0.09%+$445.3K
Neurogene Inc0115,000+115,000$0$3.20M0.08%+$3.20M
iBio Inc2,600,0002,600,0000$4.55M$3.07M0.08%-$1.48M
ArriVent Biopharma Inc0100,000+100,000$0$3.03M0.08%+$3.03M
OnKure Therapeutics IncCL A1,825,6991,088,000-737,699$8.33M$2.96M0.08%-$5.36M
CytomX Therapeutics Inc0535,000+535,000$0$1.46M0.04%+$1.46M
Oculis Holding AG0132,000+132,000$0$1.23M0.03%+$1.23M
Nyxoah SASHS
SHS
843,461479,000-364,461$1.43M$661.0K0.02%-$764.4K
Aprea Therapeutics Inc350,000350,0000$280.8K$262.5K0.01%-$18.3K
Abbott Laboratories1,400,0000-1,400,000$127.04M$0—-$127.04M
Alcon Inc.(ALC)500,0000-500,000$33.55M$0—-$33.55M
Alto Neuroscience, Inc.(ANRO)785,0000-785,000$20.72M$0—-$20.72M
AstraZeneca PLC(AZN)450,0000-450,000$85.33M$0—-$85.33M
Beta Bionics, Inc.(BBNX)1,600,0000-1,600,000$25.07M$0—-$25.07M
BioCryst Pharmaceuticals, Inc.(BCRX)8,300,0000-8,300,000$83.00M$0—-$83.00M
Bristol-Myers Squibb Company(BMY)800,0000-800,000$46.10M$0—-$46.10M
Damora Therapeutics, Inc.(DMRA)575,0000-575,000$14.96M$0—-$14.96M
GE HealthCare Technologies Inc.(GEHC)450,0000-450,000$28.80M$0—-$28.80M
Madrigal Pharmaceuticals, Inc.(MDGL)65,0000-65,000$34.90M$0—-$34.90M
Monopar Therapeutics Inc.(MNPR)75,7270-75,727$7.01M$0—-$7.01M
Myriad Genetics, Inc.(MYGN)5,735,0000-5,735,000$32.75M$0—-$32.75M
Rapport Therapeutics, Inc.(RAPP)730,0000-730,000$30.42M$0—-$30.42M
Regeneron Pharmaceuticals, Inc.(REGN)40,0000-40,000$24.94M$0—-$24.94M
Repligen Corporation(RGEN)400,0000-400,000$54.58M$0—-$54.58M
Revolution Medicines, Inc.(RVMD)450,0000-450,000$84.28M$0—-$84.28M
Sagimet Biosciences Inc.COM SER A(SGMT)535,4520-535,452$4.14M$0—-$4.14M
Surrozen, Inc.(SRZN)304,6690-304,669$7.91M$0—-$7.91M
Tenax Therapeutics, Inc.(TENX)53,4390-53,439$777.5K$0—-$777.5K
uniQure N.V.SHS(QURE)935,0000-935,000$43.07M$0—-$43.07M
Page 1 of 1
Vestal Point Capital, LP — 13F Holdings — Q3 2026 | TickerTrail